Verve Therapeutics Revenue

ChengDu ShengNuo Biotec had revenue of 184.34M CNY in the quarter ending March 31, 2025, with 77.15% growth. This brings the company's revenue in the last twelve months to 536.35M, up 17.22% year-over-year. In the year 2024, ChengDu ShengNuo Biotec had annual revenue of 456.07M with 4.84% growth.

Revenue (ttm)

536.35M

Revenue Growth

+17.22%

P/S Ratio

11.29

Revenue / Employee

388.38K

Employees

1,381

Market Cap

6.06B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	456.07M	21.05M	4.84%
Dec 31, 2023	435.02M	39.30M	9.93%
Dec 31, 2022	395.72M	9.19M	2.38%
Dec 31, 2021	386.53M	7.76M	2.05%
Dec 31, 2020	378.77M	52.03M	15.92%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hengrui Medicine	29.19B
Shenzhen Mindray Bio-Medical Electronics	35.59B
WuXi AppTec	41.48B
Sichuan Biokin Pharmaceutical	5.82B
Zhangzhou Pientzehuang Pharmaceutical.,	10.76B
Aier Eye Hospital Group	21.81B
Shanghai United Imaging Healthcare	10.43B
Yunnan Baiyao Group Co.,Ltd	40.10B

Revenue Rankings